Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.
|Articles|April 1, 2007
For Genital Lesions: Show While You Tell
It is sometimes difficult for women with genital warts to visualize their lesions. Offer patients a hand-held mirror so that they can see what the lesions look like, and recommend that they use a similar mirror at home to monitor the lesions' size and number.
Advertisement
It is sometimes difficult for women with genital warts to visualize their lesions. Offer patients a hand-held mirror so that they can see what the lesions look like, and recommend that they use a similar mirror at home to monitor the lesions' size and number. This is especially important when a conservative treatment approach is chosen. The mirror can also be used to teach vaginal self-examination.
- Tysha S. Holmes, PA-C
Columbia, SC
Advertisement
Related to this article
FDA approved Pfizer-BioNTech’s XFG-adapted COMIRNATY formula for adults 65 and older and high-risk people aged 5 to 64 years.
A Vaccine Integrity Project review found influenza, COVID-19, and RSV immunizations continue to protect against severe illness, hospitalization, and death.
FDA approved bictegravir/lenacapavir for adults with suppressed HIV-1 and no known or suspected component resistance.
Advertisement
Advertisement
Trending on Patient Care Online
1
Most Adolescents With Colorectal Cancer Diagnosed at Advanced Stage, Study Finds
2
Updated Freenome CRC Blood Test Detects 18.2% of Advanced Precancerous Lesions
3
Building Clinician Confidence to Prescribe HIV PrEP in Primary Care
4
PrEP Deserts: Why HIV Prevention Still Misses Those at Risk
5